In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hisamitsu Pharmaceutical Co.,Inc.

https://global.hisamitsu/

Latest From Hisamitsu Pharmaceutical Co.,Inc.

Finance Watch: Scion Life Sciences Launches With $310m Inaugural VC Fund

Private Company Edition: Scion’s first fund exceeded its initial $250m fundraising goal. Also, The Column Group’s incubator raised a $400m-plus fund and Seroba’s fourth fund reaches $134m, while Neurona raised a $120m financing and Cour closed a $105m series A round.

Financing Innovation

Deal Watch: Novartis Partners In CNS Gene Therapies A Second Time With Voyager

Plus deals involving AstraZeneca/Allorion, Concentra/Theseus, Janssen/MeiraGTx, Lilly/Fauna and more.

Deal Watch Business Strategies

Finance Watch: Though Flush With Cash, Theseus Seeks Alternatives, Gets Two Quick Offers

Restructuring Edition: OrbiMed/Foresite and Concentra responded quickly after Theseus implemented a 72% workforce reduction and began a search for strategic alternatives despite having $225.4m in cash. REGENXBIO, Novavax and Lyell also revealed job cuts despite large cash stockpiles.

Restructuring Financing

Aurobindo Reverses Roles With Pfizer As It Drops Pin On Indonesia: What’s The Draw?

Aurobindo’s acquisition of 15 brands from Pfizer and Viatris to gain entry to Indonesia marks a role reversal of sorts as Pfizer has been licensing generics from Aurobindo. Scrip takes a look at some of the opportunities and challenges in this growing Southeast Asian market.

Deals Commercial
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
    • OTC, Consumer
    • Drug Delivery
      • Transdermal
  • Other Names / Subsidiaries
    • CRCC Media Co.,Ltd. (Fukuoka)
    • Saga City-Vision Co.,Ltd. (Saga)
    • Taiyo Co.,Ltd (Saga)
    • Kyudo Co.,Ltd (Saga)
    • Hisamitsu Agency Co.,Ltd. (Fukuoka)
    • Hisamitsu U.S., Inc.
    • Hisamitsu America, Inc.
    • Noven Pharmaceuticals, Inc.
    • Hisamitsu Farmaceutica do Brasil Ltda.
    • Hisamitsu UK Ltd.
    • Hisamitsu Italia S.r.l.
    • Hisamitsu Vietnam Pharmaceutical Co.,Ltd.
    • Hisamitsu Pharmaceutical(China)Co.,Ltd.
    • Hisamitsu Pharmaceutical Technology Consulting(Beijing) Co.,Ltd.
    • Hisamitsu Pharmaceutical (Hong Kong)Co.,Ltd.
    • PT. Hisamitsu Pharma Indonesia
UsernamePublicRestriction

Register